|
N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-ethylpyrrole-2-carboxamide;hydrochloride |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
5beta,6alpha-Bis[4-[(4,5-dibromo-1H-pyrrole-2-yl)carbonylaminomethyl]-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
H
N
NH
O
N
Br
Br
N
H
N
N
N
H
N
H
N
NH
2
N
H
O
Br
Br
HN
|
Acinetobacter Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
ZINC Lactate |
Depiction based on curated SMILES
CH
3
O
_
O
HO
CH
3
O
_
O
HO
2+
Zn
|
Acinetobacter |
PNAG |
Preclinical (in vitro) |
Peng Q, et al. 2020. Sci Rep |
|
TILUDRONATE DISODIUM |
Depiction based on curated SMILES
O
+
Na
+
Na
Cl
_
O
HO
O
P
_
O
OH
P
S
|
Bacillus Clostridium |
Collagenase Collagenase |
Preclinical (in vitro) Preclinical (in vitro) |
Alhayek A, et al. 2022. J Med Chem
|
|
ALENDRONATE SODIUM |
Depiction based on curated SMILES
OH
P
O
OH
OH
P
O
OH
_
O
H
2
N
+
Na
|
Bacillus Clostridium |
Collagenase Collagenase |
Preclinical (in vitro) Preclinical (in vitro) |
Alhayek A, et al. 2022. J Med Chem
|
|
2-[(2E)-2-[(3,5-dibromo-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[2-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
HO
Br
Br
N
N
H
S
O
F
F
F
HN
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2E)-2-[(3,5-dibromo-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[3-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
OH
Br
Br
N
N
H
S
O
F
F
F
NH
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2E)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[2-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
NH
F
F
F
CH
3
O
S
NH
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2E)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-N-(4-fluorophenyl)-2-sulfanylideneacetamide |
Depiction based on curated SMILES
F
HN
O
CH
3
S
HN
N
HO
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2Z)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[3-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
NH
F
F
F
CH
3
O
S
NH
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
| | |